Provided by Tiger Trade Technology Pte. Ltd.

NANOBIOTIX SPON ADS EACH REP 1 ORD SHS

35.88
+1.484.30%
Post-market: 35.880.00000.00%16:15 EDT
Volume:99.77K
Turnover:3.53M
Market Cap:1.82B
PE:-61.12
High:35.96
Open:34.63
Low:34.63
Close:34.40
52wk High:57.14
52wk Low:10.07
Shares:50.71M
Float Shares:35.58M
Volume Ratio:0.66
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5871
EPS(LYR):-0.5871
ROE:--
ROA:-10.06%
PB:-18.76
PE(LYR):-61.12

Loading ...

Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology

GlobeNewswire
·
Apr 20

Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright

TIPRANKS
·
Apr 13

Nanobiotix Sa : Guggenheim Raises Target Price to $36 From $26

THOMSON REUTERS
·
Apr 02

Nanobiotix price target raised to $37 from $26 at Leerink

TIPRANKS
·
Apr 01

Earnings Flash (NBTX) Nanobiotix Posts 2025 Revenue 32.6M Euros

MT Newswires Live
·
Apr 01

Earnings Flash (NBTX) Nanobiotix Posts 2025 Per-Share Loss 0.50 Euro

MT Newswires Live
·
Apr 01

Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

Benzinga Earnings
·
Apr 01

Press Release: NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

Dow Jones
·
Apr 01

Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright

TIPRANKS
·
Mar 31

Nanobiotix presents first data from CONVERGE study

TIPRANKS
·
Mar 30

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

GlobeNewswire
·
Mar 30

Press Release: NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

Dow Jones
·
Mar 27

Nanobiotix Denies Takeover Speculations

MT Newswires Live
·
Mar 26

Nanobiotix says ‘no such intention’ for company to acquire control

TIPRANKS
·
Mar 25

Press Release: NANOBIOTIX Statement Regarding Recent Media Speculation

Dow Jones
·
Mar 25

NANOBIOTIX SPON ADS EACH REP 1 ORD SHS (NBTX.US) Surges on Acquisition Speculation Involving Johnson & Johnson (JNJ.US)

Stock News
·
Mar 25